Home
>
National Drug Code (NDC)
>
ALAVERT ALLERGY
ALAVERT ALLERGY - 0573-2621-19 - (loratadine)
Drug Information of ALAVERT ALLERGY
| Product NDC: | 0573-2621 |
| Proprietary Name: | ALAVERT ALLERGY |
| Non Proprietary Name: | loratadine |
| Active Ingredient(s): | 10 mg/1 & nbsp; loratadine |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, ORALLY DISINTEGRATING |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of ALAVERT ALLERGY
| Product NDC: | 0573-2621 |
| Labeler Name: | Pfizer Consumer Healthcare |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | NDA021375 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20021219 |
Package Information of ALAVERT ALLERGY
| Package NDC: | 0573-2621-19 |
| Package Description: | 3 BLISTER PACK in 1 CARTON (0573-2621-19) > 6 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK |
NDC Information of ALAVERT ALLERGY
| NDC Code | 0573-2621-19 |
| Proprietary Name | ALAVERT ALLERGY |
| Package Description | 3 BLISTER PACK in 1 CARTON (0573-2621-19) > 6 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK |
| Product NDC | 0573-2621 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | loratadine |
| Dosage Form Name | TABLET, ORALLY DISINTEGRATING |
| Route Name | ORAL |
| Start Marketing Date | 20021219 |
| Marketing Category Name | NDA |
| Labeler Name | Pfizer Consumer Healthcare |
| Substance Name | LORATADINE |
| Strength Number | 10 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes |
